Category: TeleflexSyndicate content

GPOs: Teleflex inks dialysis deal with Premier

December 3, 2014 by Val Kennedy

Teleflex enters a 3-year agreement with group purchasing organization Premier for its Arrow dialysis access products.

GPOs: Teleflex inks dialysis deal with Premier

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Teleflex wins another $2m from the Army for Semprus tech

October 28, 2014 by Brad Perriello

Teleflex says it won a grant from the U.S. Army worth more than $2 million to develop an anti-microbial orthopedic device using Teleflex's Semprus Sustain coating technology.

Teleflex wins $2m Army grant for Semprus tech

Teleflex (NYSE:TFX) said today that it landed a U.S. Army grant for the Semprus Sustain anti-microbial coating technology it was having a hard time with earlier this year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Teleflex issues Class I recall of pediatric anesthesia devices

October 8, 2014 by Alexander Soule

Teleflex issues a Class I recall of its pediatric anesthesia devices over concerns that certain components could break during use, resulting in serious injury or even death.

Teleflex issues Class I recall of pediatric anesthesia devices

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Report: Teleflex expands in Czech Republic

September 25, 2014 by Brad Perriello

Teleflex reportedly plans an expansion of its catheter production operations in the Czech Republic.

Report: Teleflex expands in Czech Republic

Teleflex (NYSE:TFX) reportedly plans to expand its catheter production operations in the Czech Republic, where it already has some 700 employees.

Lack of FDA approval is no longer a deal-breaker for a big exit | The week in medtech M&A

August 6, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Report: Medtech M&A exits don't hinge on FDA approval; White House rails against Medtronic-style corporate inversions; Smith & Nephew CEO: We've been an M&A target for 10 years; More mega-merger talk from medtech giants; Baxter sheds vaccines biz for $635M

Report: Medtech M&A exits don't hinge on FDA approval

July 31, 2014 by Arezu Sarvestani

Report: Medtech M&A no longer hinges on FDA approval

More mega-merger talk from medtech giants | MassDevice.com On Call

August 4, 2014 by Arezu Sarvestani

Leadership at Johnson & Johnson and Teleflex weigh in on the multi-billion-dollar mergers that are shifting the landscape of the medical device industry.

MassDevice.com On Call

MASSDEVICE ON CALL — More medical device giants offered their 2¢ on high-dollar mega-mergers, joining other companies in saying that they aren't planning any billion-dollar buys just yet.

Teleflex delivers a beat-and-raise Q2

July 31, 2014 by Arezu Sarvestani

Teleflex gets some Wall Street love after reporting double-digit revenue growth in Q2, beating analysts' expectations and raising its adjusted per-share earnings guidance for the rest of the year.

Teleflex delivers a beat-and-raise Q2

Wayne, Pa.-based Teleflex (NYSE:TFX) served up some good news today with strong numbers for its 2nd quarter and an increased outlook on the year.

The company posted an 11.4% increase in sales and an 11.3% increase in profits, with adjusted earnings coming in almost 19% higher year-over-year.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp